Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate
This author has yet to write their bio.Meanwhile lets just say that we are proud NCCS Staff contributed a whooping 8 entries.
The National Coalition for Cancer Survivorship (NCCS) joined other member organizations of the Cancer Leadership Council (CLC) in a letter to Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma, urging “immediate action” by CMS to withdraw an interim final rule that implements a most favored nation (MFN) model in Medicare Part B drug […]
The National Coalition for Cancer Survivorship (NCCS) recently submitted comments urging the Department of Health and Human Services (HHS) to withdraw a recent proposed rule that would require the review of HHS rules that are more than 10 years old. If implemented, this proposed rule would automatically eliminate regulations that are 10 years old or […]
The National Coalition for Cancer Survivorship (NCCS) opposes the Most Favored Nation (MFN) Model for reimbursing Medicare Part B drugs. The MFN Model was released by the Trump administration last week as an Interim Final Rule. This model would drastically change the way Medicare pays for certain drugs, including many oncology drugs, and could limit […]
(Silver Spring, MD) – The National Coalition for Cancer Survivorship (NCCS) presented the 5th annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care on November 18 to the 2020 winners: Julia H. Rowland, PhD and Thomas J. Smith, MD. Named for former NCCS CEO Ellen Stovall, who died in 2016 due to long-term […]
NCCS recently submitted a comment letter to the Centers for Medicare and Medicaid (CMS) regarding the Medicare physician fee schedule for calendar year 2021. The comment letter focuses on telehealth-related provisions of the proposed rule, as we are learning from our findings from our Telehealth Project that both patients and providers need more tools and […]
NCCS joined with other cancer patient and provider groups in a comment letter to the Centers for Medicare and Medicaid Services (CMS) regarding the proposed rule related to the hospital outpatient prospective payment system. Among the issues outlined in the letter is a concern about an additional reduction in payment for drugs in the 340B […]
NCCS joined with a group of patient and provider advocacy groups in a letter to the National Academy of Medicine (NAM) on vaccine allocation. In the letter, the groups articulate the substantial risk that cancer patients face during the pandemic and shared data on the negative outcomes of patients with cancer and concurrent COVID-19. The […]
NCCS is pleased to announce the 2020 winners of the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care are Julia H. Rowland, PhD and Thomas J. Smith, MD. They will be recognized at the 2020 Virtual Stovall Award Reception on Wednesday, November 18 at 7:00 p.m. ET. The esteemed selection committee chose from […]
The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action
National Coalition for Cancer Survivorship
8455 Colesville Road | Suite 930 | Silver Spring, MD 20910
877-NCCS-YES | info@canceradvocacy.org
Privacy Policy | Terms and Conditions
Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.
Founder
Northeast Regional Cancer Institute
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”
—Karen M. Saunders
President, Northeast Regional Cancer Institute
